HbA1c blir kompletterande metod för diagnostik av diabetes. Samordnat införande i Sverige januari 2014
Sammanfattning
Starting in January 2014 Sweden will adopt the WHO recommendations from 2011 for the use of HbA1c in the diagnosis of diabetes mellitus (decision limit =48 mmol/mol). For patients with HbA1c 42–47 mmol/mol life style intervention, a global risk assessment and a follow up within 6–12 months is recommended.